Till Koch

University Name

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

70%

Virology

100%

Sars-cov-2

40%

Vaccinology

40%

Immunotherapy

40%

Antibodies

30%

Mucosal Immunology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach

Article Link

Year:

2024

Focussed Assessment with Sonography in acute Lassa Fever (FASLa): Development of a point-of-care protocol and description of common ultrasound findings.

Article Link

Year:

2023

Early neuroborreliosis with leg paresis mimicking herpes zoster

Article Link

Year:

2023

Endocarditis guidelines: call for an interdisciplinary approach

Article Link

Year:

2023

High burden of RSV and influenza in patients presenting with suspected pneumonia in the emergency room of a German tertiary hospital in fall of 2022

Article Link

Year:

2023

Prospective Single-Center Cohort Study on HIV Pre-exposure Prophylaxis Reveals Transient but Relevant Elevations in Transaminase Levels in Some Participants Albeit Otherwise High Tolerability

Article Link

Year:

2023

Pharmacokinetics of ribavirin in the treatment of Lassa fever: An observational clinical study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria

Article Link

Year:

2022

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

Article Link

Year:

2022

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

Article Link

Year:

2022

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series

Article Link

Year:

2021

[Mild COVID-19 disease in healthcare workers at a German university clinic : The "first wave" at the University Medical Center Hamburg-Eppendorf].

Article Link

Year:

2021

Less than you’d think—a prospective study on MRSA-colonization in healthy travellers

Article Link

Year:

2021

Correlates of Vaccine-Induced Protection against SARS-CoV-2

Article Link

Year:

2021

Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria.

Article Link

Year:

2020

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins

Article Link

Year:

2020

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.

Article Link

Year:

2020

Collaborators9

Leonie Marie Weskamm

University Medical Center Hamburg-Eppendorf

GERMANY

Bart L. Haagmans

Principal Investigator / Associate Professor - PhD

Erasmus MC

NETHERLANDS

Mirjam Groger

Bernhard Nocht Institute for Tropical Medicine

GERMANY

Johann von Felden

University Medical Center Hamburg-Eppendorf

GERMANY

Marcel Mueller

Group leader/ Prof. Dr. rer. nat.

Charité - Universitätsmedizin Berlin

GERMANY

Stephan Günther

Head

Bernhard-Nocht-Institut für Tropenmedizin

GERMANY

Michael Ramharter

Professor

Bernhard-Nocht-Institut für Tropenmedizin

GERMANY

Bruna Mara Silva Seco

University of Idaho

UNITED STATES

Dorothee Schwinge

University Medical Center Hamburg-Eppendorf

GERMANY

How do I reach out?

Meet Kite AI